Background and Aims
Methods
Results
Conclusions
Abbreviations:
BE (Barrett’s esophagus), CE-D (complete eradication of dysplasia), CE-IM (complete eradication of intestinal metaplasia), cRFA (circumferential radiofrequency ablation), RFA (radiofrequency ablation)Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Gastrointestinal EndoscopyReferences
- Radiofrequency ablation in Barrett's esophagus with dysplasia.N Engl J Med. 2009; 360: 2277-2288
- Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multicenter trial.Endoscopy. 2010; 42: 781-789
- Durability of radiofrequency ablation in Barrett's esophagus with dysplasia.Gastroenterology. 2011; 141: 460-468
- ACG clinical guideline: diagnosis and management of Barrett's esophagus.Am J Gastroenterol. 2016; 111: 30-50
- Endoscopic management of Barrett's esophagus: European Society of Gastrointestinal Endoscopy (ESGE) position statement.Endoscopy. 2017; 49: 191-198
- Radiofrequency ablation for total Barrett's eradication: a description of the endoscopic technique, its clinical results and future prospects.Endoscopy. 2008; 40: 1033-1040
- Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device.Surg Endosc. 2006; 20: 125-130
- A single-step sizing and radiofrequency ablation catheter for circumferential ablation of Barrett's esophagus: results of a pilot study.United Eur Gastroenterol J. 2018; 6: 990-999
- Safety signal for the simple double ablation regimen when using the Barrx 360 Express radiofrequency ablation balloon catheter.Gastroenterology. 2017; 153: 614
- Self-sizing radiofrequency ablation balloon for eradication of Barrett's esophagus: results of an international multicenter randomized trial comparing 3 different treatment regimens.Gastrointest Endosc. 2019; 90: 415-423
- Adverse events after radiofrequency ablation in patients with barrett's esophagus: a systematic review and meta-analysis.Clin Gastroenterol Hepatol. 2016; 14: 1086-1095
- Safety of prior endoscopic mucosal resection in patients receiving radiofrequency ablation of Barrett's esophagus.Clin Gastroenterol Hepatol. 2012; 10: 150-154
- Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II).Gut. 2016; 65: 555-562
- The management of antithrombotic agents for patients undergoing GI endoscopy.Gastrointest Endosc. 2016; 83: 3-16
- Efficacy and safety outcomes of multimodal endoscopic eradication therapy in Barrett's esophagus-related neoplasia: a systematic review and pooled analysis.Gastrointest Endosc. 2017; 85: 482-495
- Clinical outcomes following recurrence of intestinal metaplasia after successful treatment of Barrett's esophagus with radiofrequency ablation.Am J Gastroenterol. 2017; 112: 87-94
- Radiofrequency ablation and endoscopic mucosal resection for dysplastic Barrett’s esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry.Gastroenterology. 2013; 145: 87-95
- Remission of Barrett's esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study.Gastroenterology. 2013; 145: 96-104
- Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a US Multicenter Consortium.Gastroenterology. 2013; 145: 79-86
- Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia.Dis Esophagus. 2017; 31: 1-8
- Timeline and location of recurrence following successful ablation in Barrett's oesophagus: an international multicentre study.Gut. 2019; 68: 1379-1385
- Higher rate of Barrett's detection in the first year after successful endoscopic therapy: meta-analysis.Am J Gastroenterol. 2018; 113: 959-971
- Trends in esophageal adenocarcinoma incidence and mortality.Cancer. 2013; 119: 1149-1158
- Increasing incidence of Barrett's oesophagus in the general population.Gut. 2005; 54: 1062-1066
Article info
Publication history
Footnotes
DISCLOSURE: The following authors disclosed financial relationships: A. Kahn, C. L. Leggett, F.C. Ramirez: Research support from NinePoint Medical. M. B. Wallace: Consultant for Virgo Inc, Cosmo/Aries Pharmaceuticals, Anx Robotica (2019), Covidien, GI Supply, Endokey, Endostart, and Boston Scientific; research support from Fujifilm, Boston Scientific, Olympus, Medtronic, Ninepoint Medical, and Cosmo/Aries Pharmaceuticals; stock or stock options from Virgo Inc; general support from Synergy Pharmaceuticals, Boston Scientific, and Cook Medical. K. K. Wang: Research support from Erbe, EndoRotor, and Fujifilm. P. G. Iyer: Research support from Exact Sciences, C2 Therapeutics, and Intromedic Inc; consultant for Medtronic, Symple Surgical, and CSA Medical. All other authors disclosed no financial relationships.
If you would like to chat with an author of this article, you may contact Dr Iyer at [email protected]